An exciting opportunity has arisen in LSTM's  Clinical Sciences team for an experienced Research Associate to join us. The Role:

Why is improving screening for tuberculosis of the lungs important?

Cochrane reviews on tests for tuberculosis disease and tuberculosis drug resistance

The Cochrane Infectious Diseases Group Review of Hydroxychloroquine for COVID-19 has been recognised with the inaugural Harding Prize for Useful and Trustworthy Communication.

During March 2022, the CIDG published two new reviews in Issue 3, 2022 of the 

We talk with highly-valued former staff member Dr Marylou Murray, who worked with the READ-It team as a Clinical Research Associate and CIDG author from January 2019 to January 2020 What Marylou did before joining Cochrane Infectious Diseases Group (CIDG)

Mass drug administration means giving every person living in a village or region a drug, irrespective of whether they have the disease or not. It’s an approach used in some disease control programmes in Africa, Asia, and South America since the 1930s. They are often steeped in controversy: some specialists believing they are effective, whilst others seeing them as being imperialistic and imposed.

Why is improving the diagnosis of high HIV viral load infection important?

During January 2022, we published one protocol and one updated review in Issue 1, 2022 of the Cochrane Database of Systematic Reviews.